Foscarnet Sodium NDC 43066-089

NDC codes

FDA NDC Directory

Product NDC (as listed)43066-089Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43066-0089Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43066-089-10	43066008910	10 BAG in 1 CARTON (43066-089-10) / 250 mL in 1 BAGMarketed from Aug 28, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Foscarnet Sodium
Generic name (nonproprietary): foscarnet sodium
Active ingredients: Foscarnet sodium — 6000 mg/250mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Baxter Healthcare Corporation
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213001
Marketing start: Aug 28, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Chelating Activity (Mechanism)DNA Polymerase Inhibitors (Mechanism)Pyrophosphate Analog (EXT)
Identifiers: Product ID 43066-089_f3b7e70d-5ed4-4d9a-a11b-84c3c4deb607SPL ID f3b7e70d-5ed4-4d9a-a11b-84c3c4deb607SPL set ID 8a7caffd-9d8a-4d45-ad48-70d511a89c29RxCUI 1734377UNII 964YS0OOG1
Pharmacologic class: Pyrophosphate Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N443066008910 followed by a unit qualifier and the quantity

Package 43066-0089-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 28, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS CMV Retinitis Foscarnet sodium injection is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). Combination therapy with foscarnet sodium Injection and ganciclovir is indicated for patients who have relapsed after monotherapy with either drug. SAFETY AND EFFICACY OF FOSCARNET SODIUM INJECTION HAVE NOT BEEN ESTABLISHED FOR TREATMENT OF OTHER CMV INFECTIONS (e.g., PNEUMONITIS, GASTROENTERITIS); CONGENITAL OR NEONATAL CMV DISEASE; OR NONIMMUNOCOMPROMISED INDIVIDUALS. Mucocutaneous Acyclovir Resistant HSV Infections Foscarnet sodium injection is indicated for the treatment of acyclovir-resistant mucocutaneous HSV infections in immu…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213001

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213001
Product	Strength	Form · route	Labeler	Product NDC
Foscarnet Sodium	Foscarnet sodium 24 mg/mL	Injection, SolutionIntravenous	Sagent Pharmaceuticals	25021-189
Foscarnet Sodium	Foscarnet sodium 24 mg/mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-389